ECPR for witnessed cardiac arrest with shockable rhythm
Part of Heart & circulation clinical trials.
This trial tests whether using a machine to pump blood and oxygen (ECPR) right after a witnessed cardiac arrest with a shockable rhythm can improve survival. You might be eligible if you had a witnessed arrest, got bystander CPR, and your first rhythm was shockable, as long as the emergency team can reach the hospital in 30 minutes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- Your cardiac arrest was witnessed by someone.
- A bystander started CPR on you.
- Your first heart rhythm was a shockable type (ventricular fibrillation or pulseless ventricular tachycardia).
- You have no prior 'do not resuscitate' order and no known severe disease that would make survival unlikely.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a rapid way to give life support using a heart-lung bypass machine (ECPR) to people experiencing a sudden cardiac arrest that doesn't stop with defibrillators or standard CPR. The goal is to start this treatment within 20 minutes of the emergency call, which may improve chances of survival.
This study tests emergency treatments for people who have had a cardiac arrest (heart stops beating) outside the hospital. It looks at two groups: people whose hearts stop despite CPR efforts, and people whose hearts have restarted. The goal is to see if these treatments can help patients survive and recover better.
This trial tests a targeted approach to manage oxygen levels in the brain for patients who received ECMO (a machine that does the heart and lung work) after a cardiac arrest that did not respond to standard CPR. The goal is to improve brain recovery and outcomes.
This study records information about people who suffer an out-of-hospital cardiac arrest and receive automatic chest compressions. It focuses on specific heart rhythms and emergency timing, which may help improve future emergency treatment.
This study looks at a treatment called ECMO, a machine that does the work of the heart and lungs, to help people whose heart has stopped and does not restart with standard CPR. Researchers want to learn if placing ECMO at the scene can improve survival.
This trial is studying the blood biomarkers and platelet characteristics in patients who receive CPR and are then placed on a heart-lung bypass machine (ECPR). It aims to understand how these biological markers relate to patient outcomes.
Hear when a new Cardiac Arrest trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.